Press release
Medroxyprogesterone Acetate Market to Expand with Significant CAGR During 2017 - 2025
The synthetic version of progesterone, 17α-hydroxy-6α-methylprogesterone acetate is also known by the name Medroxyprogesterone Acetate. Medroxyprogesterone acetate is a more potent derivative of medroxyprogesterone and what is normally injected is its acetate derivative. Medroxyprogesterone acetate is administered every 3 months which in turn prevents ovulation and follicular maturation in endometrial thinning producing a contraceptive effect.A sample of this report is available upon request @ https://www.persistencemarketresearch.com/samples/15688
Medroxyprogesterone Acetate Market: Drivers and Restraints
The medroxyprogesterone acetate market is driven by the increasing need for birth control measure and government initiatives to generate more awareness related to the different contraceptive methods. There are various forecasting initiatives undertaken to understand the demand of Depot medroxyprogesterone acetate (DMPA) as a birth control measure. In January 2015, the Concept Foundation contracted William Davidson Institute (WDI), to understand the demand of DMPA in low income and middle-income countries.
Manufacturers are now trying to develop low-dose injectable of medroxyprogesterone acetate through subcutaneous route so as to lower some of the side effects related to weight gain and metabolic effects.
Medroxyprogesterone Acetate Market: Segmentation
On the basis of end use the medroxyprogesterone acetate market can be segment as:
Contraceptive
Hormone replacement therapy
Treatment of endometriosis
Other
On the basis of route of administration the medroxyprogesterone acetate market can be segment as:
Oral
Parenteral
Medroxyprogesterone Acetate Market: Overview
Sayana Press a three-month, progestin-only injectable contraceptive was approved by the UK authorities in 2015. PATH along with ministries of health in Uganda and Senegal are researching on self-injection of Sayana Press and ways that it could be effective in women. Through the PATH initiatives since 2014, this contraceptive is available in remote locations in Uganda, Senegal, Niger and Burkina Faso. Sayana Press has regulatory approval in Europe and 25 other countries. In 2014, the Children’s Investment Fund Foundation (CIFF), the Bill & Melinda Gates Foundation and Pfizer Inc. decided to offer Sanaya Press to purchasers from 69 countries for US$1 per dose.
The public and the private partners announced in the London Summit to reach poorest countries by 2020 with around 12 million doses of Sayana Press. Injctables has always been a popular contraceptive method in Sub-Saharan Africa and hence the presentation of Sayana Press inj the Uniject device is expected to increase the demand. The all-in-one prefiled injection system improves safety and enhances access through non-clinical channels.
Medroxyprogesterone Acetate Market: Region-wise Outlook
In terms of geography, medroxyprogesterone acetate market has been divided into five regions including North- America, Asia- Pacific, Middle-East & Africa, Latin America and Europe. The presence of major market players, technology advancements and research investments has made North America the dominating region for the cardiac biomarkers market. Moreover, there are many startups who are trying to enter the medroxyprogesterone acetate market with new technologies and more efficacy.
Developing countries are focusing on bringing down the infact and maternal death rates by legalizing the use of injectable contraceptives. One such initiative was taken by Haryana, which became the first state in the country to implement the use of injectable contraceptives. The project would be initiated in nine blocks of the state where the injectable would be available free of costs in all district hospitals, primary health centers and community health centers.
To view TOC of this report is available upon request @ https://www.persistencemarketresearch.com/toc/15688
Medroxyprogesterone Acetate Market: Key Market Participants
Some of the medroxyprogesterone acetate market participants are Pfizer Inc., Fangtong Pharma.Co.Ltd, Gador S.A., Sigma-Aldrich Co. LLC., Teva Pharmaceutical Industries Ltd., Greenstone LLC, Serum Internation Ltd., West-Coast Pharmaceutical, Arrow Pharma Group, and Zuche Pharmaceuticals Pvt. Ltd..
The report covers exhaustive analysis on:
Market Segments
Market Dynamics
Historical Actual Market Size, 2012 - 2014
Market Size & Forecast 2015 to 2024
Supply & Demand Value Chain
Market Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Aircraft Refurbishing Market Drivers and Restraints
Regional analysis for Market includes
North America
Latin America
Europe
Asia Pacific & Japan
The Middle East and Africa
Report Highlights:
Shifting Industry dynamics
In-depth market segmentation
Historical, current and projected industry size Recent industry trends
Key Competition landscape
Strategies of key players and product offerings
Potential and niche segments/regions exhibiting promising growth
A neutral perspective towards market performance
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Medroxyprogesterone Acetate Market to Expand with Significant CAGR During 2017 - 2025 here
News-ID: 733282 • Views: …
More Releases from Persistence Market Research

Stadium Lighting Market Soars as LED Replaces Metal Halide with Longer Lifespan …
The stadium lighting market is witnessing unprecedented growth, fueled by the global shift from traditional metal halide lights to energy-efficient LED lighting systems. Metal halide lights, which have dominated stadiums for decades, typically last around 6,000 hours and require frequent replacement, leading to high maintenance costs. In contrast, modern LED stadium lights offer superior durability, water resistance, and shockproof features, with lifespans extending up to 100,000 hours. These advancements are…

Global POS Machines Market Outlook: US$ 18 Bn to US$ 49 Bn by 2033
The Point-of-Sale (POS) machines market has been experiencing significant growth over the past decade, driven by rapid technological advancements and the increasing adoption of digital payment solutions. As of 2022, the global POS machines market was valued at US$ 18,221.3 Million, and it is forecasted to reach US$ 49,365.2 Million by 2033. The market is anticipated to grow at a CAGR of 9.6% from 2023 to 2033, highlighting its robust…

How 3D Scanners Are Transforming Design, Manufacturing, and Entertainment
The 3D scanners market is witnessing remarkable growth as industries increasingly adopt advanced digital solutions for product design, quality control, and cultural documentation. A 3D scanner is defined as a device that analyzes real-world objects to collect data on their shape and appearance, enabling the creation of highly accurate digital models. These models are widely used across applications like movie and video game production, industrial design, prosthetics, reverse engineering, prototyping,…

Intermodal Transport Market Poised for Growth at a Robust CAGR Over the Next Dec …
Overview of the Market
The intermodal transport market is witnessing significant growth globally due to increasing demand for efficient, cost-effective, and environmentally sustainable logistics solutions. Intermodal transport, which involves the seamless integration of multiple transportation modes such as rail, road, and sea, ensures faster and safer movement of goods while reducing operational costs. The market's growth is being driven by the rising adoption of advanced technologies, such as automated gate systems…
More Releases for Medroxyprogesterone
Medroxyprogesterone Acetate Market, Advancing Women's Health Through Hormonal In …
Market Overview and Outlook
The global Medroxyprogesterone Acetate (MPA) Market continues to expand as pharmaceutical companies and healthcare providers rely on this synthetic progestin for a range of women's health applications. This increase is driven by rising awareness of reproductive health, expanding use in contraceptive therapies, and its role in hormone replacement therapy (HRT) for menopausal women.
Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a…
Global Medroxyprogesterone Acetate Market Imapct of AI and Automation
Medroxyprogesterone Acetate Market Impact of AI and Automation
The global Medroxyprogesterone Acetate (MPA) market was valued at approximately USD 1.2 billion in 2022 and is projected to experience a compound annual growth rate (CAGR) of around 5.8% from 2023 to 2030. This growth is driven by increasing awareness about contraceptive options, rising prevalence of hormone-related conditions, and expanding pharmaceutical applications. The market's upward trajectory reflects both a growing demand for hormonal…
Subcutaneous MedroxyProgesterone Acetate Market Analysis and Future Prospects fo …
The world of the subcutaneous medroxyprogesterone acetate market is a complex and ever-evolving landscape, shaped by consumer demands and technological advancements. In this report, we delve into the depths of this market to provide a profound and comprehensive analysis, catering to a diverse audience that includes manufacturers, suppliers, distributors, and investors. Our primary goal is to empower industry stakeholders with invaluable insights to make informed decisions in a rapidly changing…
Global MedroxyProgesterone Market Forecast 2023-2028 Under Inflation
This MedroxyProgesterone market report provides a framework for big corporations to find the most profitable business opportunities. The COVID-19 caused substantial economic turmoil and uncertainty, resulting in increased market unpredictability. Additionally, in order to acquire very detailed data on segment and sub-segment, investigators must do significant research utilizing a regression approach. In-depth research is conducted by financial specialists using both bottom-up and top-down approaches.
Get Sample Copy of MedroxyProgesterone Market Report…
Global Depot Medroxyprogesterone Injection Market Was Valued at USD 800 million …
According to Precision Business Insights (PBI), the Depot Medroxyprogesterone Injection Market is expected to be worth USD 830 million in 2022, growing at a 4.0% CAGR from 2022 to 2028. Global Depot Medroxyprogesterone Injection Market is segmented into the following types: By Type (Prescriptions & Generic Prescriptions), By End User (Hospital, Pharmacy, & Others), By Application (Contraceptive, Hormone Replacement Therapy, Treatment of Endometriosis, and Other), and Geography (North America, Europe,…
Medroxyprogesterone Acetate Market Set to Surge Significantly During 2017 – 20 …
Medroxyprogesterone Acetate Market: Key Market Participants
Some of the medroxyprogesterone acetate market participants are Pfizer Inc., Fangtong Pharma.Co.Ltd, Gador S.A., Sigma-Aldrich Co. LLC., Teva Pharmaceutical Industries Ltd., Greenstone LLC, Serum Internation Ltd., West-Coast Pharmaceutical, Arrow Pharma Group, and Zuche Pharmaceuticals Pvt. Ltd..
The synthetic version of progesterone, 17α-hydroxy-6α-methylprogesterone acetate is also known by the name Medroxyprogesterone Acetate. Medroxyprogesterone acetate is a more potent derivative of medroxyprogesterone and what is normally injected…